MIH
AGN

Meitav Investment House’s Allergan plc AGN Stock Holding History

Meitav Investment House’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,912
Closed -$320K – 491
2019
Q2 		$320K Sell
1,912
-110
-5% -$15.2K 0.02% 323
2019
Q1 		$296K Buy
2,022
+13
+0.6% +$1.89K 0.02% 318
2018
Q4 		$267K Sell
2,009
-175
-8% -$28.7K 0.02% 280
2018
Q3 		$417K Buy
+2,184
New +$401K 0.02% 348

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Meitav Investment House's AGN Position: Q3 2019 in Review

Meitav Investment House sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 1,912 shares — an estimated $320K sold.

Meitav Investment House first reported a position in AGN in Q3 2018 and held it in 4 quarters. The position peaked at $417K in Q3 2018. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Meitav Investment House reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Meitav Investment House sold 1,912 Allergan plc shares in Q3 2019, an estimated $320K.
  • Meitav Investment House first reported a position in Allergan plc in Q3 2018 and held it in 4 quarters.
  • Meitav Investment House's Allergan plc position peaked at $417K in Q3 2018.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Meitav Investment House's 13F filing for Q3 2019, filed 14 Nov 2019.